Pfizer Pivots to Cancer Drugs
Twenty years ago, Pfizer Inc. didn’t sell any drugs treating cancer. Now, it sells 17, including four that were approved in the U.S. at the end of last year, more than any other pharmaceutical company. Jared S. Hopkins, WSJ.
Glaxo Focuses on Cancer Drugs to Restock Pipeline, as it boosts spending on
developing new cancer drugs!
According to Denise Roland and Carlo Martuscelli of wall street journal
“Replenishing Lilly’s pipeline is
a key focus in upcoming years,”
Lilly CEO David Ricks.
And he did exactly what he said he would do!
Lilly swiftly scooped Loxo,
a startup cancer drug maker for $8 billion!
Editor
